Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Nebivolol on Aortic Impedance Parameters in Type 2 Diabetics

NCT00829296 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00829296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00829296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Nebivolol on Aortic Impedance Parameters in Type 2 Diabetics
Lead sponsor
University of Chicago
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2009
Completion date
April 30, 2013
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, hypertension